[go: up one dir, main page]

UY35071A - ?formulación de forma farmacéutica sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación?. - Google Patents

?formulación de forma farmacéutica sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación?.

Info

Publication number
UY35071A
UY35071A UY0001035071A UY35071A UY35071A UY 35071 A UY35071 A UY 35071A UY 0001035071 A UY0001035071 A UY 0001035071A UY 35071 A UY35071 A UY 35071A UY 35071 A UY35071 A UY 35071A
Authority
UY
Uruguay
Prior art keywords
calcium carbonate
formulation
manufacturing
solid pharmaceutical
pharmaceutical form
Prior art date
Application number
UY0001035071A
Other languages
English (en)
Inventor
Alles Rainer
Schoelkopf Joachim
Patrick A C Gane
Daniel E Gerard
Tanja Strinimann
Maxim Puchkov
Jörg Huwyler
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022552&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY35071(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of UY35071A publication Critical patent/UY35071A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C43/00—Compression moulding, i.e. applying external pressure to flow the moulding material; Apparatus therefor
    • B29C43/006—Pressing and sintering powders, granules or fibres
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/772—Articles characterised by their shape and not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mechanical Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Geology (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)

Abstract

Una forma farmacéutica de desintegración veloz oral que comprende carbonato de calcio natural o sintético funcionalizado, por lo menos un ingrediente activo y por lo menos un desintegrante, donde dicho carbonato de calcio natural o sintético funcionalizado es un producto de la reacción de carbonato de calcio natural o sintético con dióxido de carbono y uno o más ácidos, donde el dióxido de carbono se forma in situ mediante el tratamiento ácido, y/o es suministrado desde una fuente externa, y donde el comprimido se disuelve en menos de 20 segundos cuando se introduce en un entorno acuoso.
UY0001035071A 2012-10-12 2013-10-09 ?formulación de forma farmacéutica sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación?. UY35071A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12188344.1A EP2719373B1 (en) 2012-10-12 2012-10-12 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
US201261713671P 2012-10-15 2012-10-15

Publications (1)

Publication Number Publication Date
UY35071A true UY35071A (es) 2014-05-30

Family

ID=47022552

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035071A UY35071A (es) 2012-10-12 2013-10-09 ?formulación de forma farmacéutica sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación?.

Country Status (27)

Country Link
US (1) US20150283082A1 (es)
EP (2) EP2719373B1 (es)
JP (1) JP6196676B2 (es)
KR (1) KR101740835B1 (es)
CN (2) CN110742867A (es)
AR (1) AR092957A1 (es)
AU (1) AU2013328639B2 (es)
BR (1) BR112015008139B1 (es)
CA (1) CA2884912C (es)
CL (1) CL2015000893A1 (es)
CO (1) CO7350657A2 (es)
DK (2) DK2719373T3 (es)
ES (2) ES2628371T3 (es)
HR (1) HRP20191082T1 (es)
HU (1) HUE044281T2 (es)
IL (1) IL237766B (es)
MX (1) MX369779B (es)
MY (1) MY174635A (es)
PL (2) PL2719373T3 (es)
PT (1) PT2916816T (es)
RU (2) RU2676087C2 (es)
SG (1) SG11201502290SA (es)
SI (2) SI2719373T1 (es)
TR (1) TR201909173T4 (es)
TW (1) TWI583387B (es)
UY (1) UY35071A (es)
WO (1) WO2014057038A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2654577T5 (es) 2013-12-13 2021-06-17 Omya Int Ag Composición limpiadora abrasiva
US10238598B2 (en) 2013-12-16 2019-03-26 The University Of British Columbia Self-fueled particles for propulsion through flowing aqueous fluids
EP2921173A1 (en) * 2014-03-21 2015-09-23 Omya International AG Surface-reacted calcium carbonate for desensitizing teeth
EP2949708B1 (en) 2014-05-30 2018-04-04 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
CA2948606A1 (en) 2014-05-30 2015-12-03 Omya International Ag Method for the production of granules comprising surface-reacted calcium carbonate
EP2957603A1 (en) 2014-06-20 2015-12-23 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
EP3069713A1 (en) * 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3176222A1 (en) 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275537A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3275946A1 (en) * 2016-07-25 2018-01-31 Omya International AG Post treatment of surface-reacted calcium carbonate with different functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
EP3594289A1 (en) * 2018-07-13 2020-01-15 Omya International AG Surface-reacted calcium carbonate for stabilizing mint oil
CN112770777A (zh) * 2018-09-17 2021-05-07 Omya国际股份公司 包含共加工的微晶纤维素和经表面反应碳酸钙的高性能赋形剂
EP3682901A1 (en) 2019-01-21 2020-07-22 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
EP3622966A1 (en) 2018-09-17 2020-03-18 Omya International AG High performance excipient comprising co-processed microcrystalline cellulose and surface-reacted calcium carbonate
CN109749745A (zh) * 2018-12-21 2019-05-14 西北农林科技大学 一种利用土体固化溶液加固土体的方法
US11113797B1 (en) 2019-08-19 2021-09-07 Snap Inc. Passive flash imaging
BR112022021818A2 (pt) 2020-04-28 2022-12-13 Omya Int Ag Método para a produção de grânulos de fluxo livre
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
CN115551982A (zh) * 2020-05-28 2022-12-30 联合利华知识产权控股有限公司 片剂
BE1031271B1 (nl) * 2023-01-19 2024-08-19 Herdt Kris De Tablet ter verhoging van de bufferende werking van water

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
US4650699A (en) * 1983-04-18 1987-03-17 Sermetel Thixotropic alumina coating compositions, parts and methods
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US5635210A (en) 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
US20050244493A1 (en) * 2004-04-30 2005-11-03 Withiam Michael C Rapidly disintegrating tablets comprising calcium carbonate
PL2070991T3 (pl) 2007-12-12 2011-02-28 Omya Int Ag Sposób wytwarzania strącanego węglanu wapnia o powierzchni zmodyfikowanej chemicznie
JP5490691B2 (ja) * 2008-06-12 2014-05-14 株式会社三和化学研究所 炭酸カルシウム含有速崩壊性製剤
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
EP2198857A1 (en) * 2008-12-19 2010-06-23 Ratiopharm GmbH Oral dispersible tablet
EP2210591B1 (en) * 2009-01-26 2016-03-30 Shin-Etsu Chemical Co., Ltd. Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
JP4562797B1 (ja) * 2009-05-29 2010-10-13 マイラン製薬株式会社 沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
PL2264108T3 (pl) 2009-06-15 2012-07-31 Omya Int Ag Sposób wytwarzania przereagowanego powierzchniowo węglanu wapnia, z wykorzystaniem słabego kwasu
EP2377900B1 (en) * 2010-04-16 2013-07-31 Omya Development AG Process to prepare surface-modified mineral material, resulting products and uses thereof

Also Published As

Publication number Publication date
MX2015004234A (es) 2015-06-10
KR101740835B1 (ko) 2017-05-26
CL2015000893A1 (es) 2015-08-28
PL2916816T3 (pl) 2019-09-30
IL237766A0 (en) 2015-05-31
SI2719373T1 (sl) 2017-07-31
KR20150063444A (ko) 2015-06-09
WO2014057038A1 (en) 2014-04-17
RU2018127317A (ru) 2019-03-14
PL2719373T3 (pl) 2017-10-31
JP2015533140A (ja) 2015-11-19
BR112015008139A2 (pt) 2017-07-04
SG11201502290SA (en) 2015-04-29
HRP20191082T1 (hr) 2019-10-18
EP2916816B1 (en) 2019-03-27
PT2916816T (pt) 2019-06-28
EP2719373A1 (en) 2014-04-16
RU2015115916A (ru) 2016-11-27
TW201438722A (zh) 2014-10-16
CN110742867A (zh) 2020-02-04
RU2018127317A3 (es) 2022-03-24
DK2916816T3 (da) 2019-07-01
TR201909173T4 (tr) 2019-07-22
AU2013328639B2 (en) 2016-09-15
CA2884912C (en) 2018-01-02
US20150283082A1 (en) 2015-10-08
RU2676087C2 (ru) 2018-12-26
TWI583387B (zh) 2017-05-21
HUE044281T2 (hu) 2019-10-28
CN104768531A (zh) 2015-07-08
AU2013328639A8 (en) 2015-05-14
BR112015008139B1 (pt) 2022-06-07
AR092957A1 (es) 2015-05-06
MY174635A (en) 2020-05-04
CA2884912A1 (en) 2014-04-17
EP2719373B1 (en) 2017-04-19
MX369779B (es) 2019-11-21
ES2628371T3 (es) 2017-08-02
DK2719373T3 (en) 2017-07-03
JP6196676B2 (ja) 2017-09-13
AU2013328639A1 (en) 2015-04-02
EP2916816A1 (en) 2015-09-16
ES2732841T3 (es) 2019-11-26
IL237766B (en) 2021-07-29
CO7350657A2 (es) 2015-08-10
SI2916816T1 (sl) 2019-08-30

Similar Documents

Publication Publication Date Title
UY35071A (es) ?formulación de forma farmacéutica sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación?.
UY35070A (es) ?Sistemas de administración y formulación de fármacos de retención gástrica, y método para su preparación usando carbonato de calcio funcionalizado?.
UY36313A (es) Composición que comprende un carbonato de calcio reaccionado en la superficie como agente antiaglomerante, y método para producirla
BR112014004460A2 (pt) material polimérico para um recipiente isolado
CL2015002145A1 (es) Preparación, usos y formas sólidas de ácido obeticólico (divisional de solicitud n° 3475-2014)
BR112015009329A2 (pt) material polimérico para um recipiente isolado
BR112015028313A2 (pt) um sistema de preparação de bebidas, uma cápsula e um método para formação de uma bebida
PE20140255A1 (es) Tableta dispersable en forma oral
MX2016014529A (es) Metodos para formar licor de tratamiento acuoso.
NZ631100A (en) Soft chewable pharmaceutical products
MX2017008937A (es) Carbonato de calcio tratado en la superficie con estabilidad mejorada en ambientes con un ph de 4.5 a 7.
BR112013028440A2 (pt) composições e métodos que compreendem variantes de serina protease
EA201171399A1 (ru) Способ и композиция для улучшения всасывания лекарственных средств
WO2015086843A3 (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide for beneficially influencing blood lipid levels by modifying the intestinal microbiota
MX2014014662A (es) Manufactura de degarelix.
BR112014030680A2 (pt) forma de dosagem efervescente
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
AR076576A1 (es) Procedimiento para estabilizar un suplemento dietetico para facilitar la salud de las articulaciones en seres humanos
MX2012007393A (es) Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.
CL2020001926A1 (es) Uso de carbonato de calcio funcionalizado como ingrediente activo.
WO2015074667A3 (en) Composition for dermatitis
BR112015014739A2 (pt) carbonato hidróxido de magnésio como excipiente em preparações farmacêuticas tendo liberação melhorada do ingrediente ativo
AR093922A1 (es) Composicion farmaceutica que contiene telmisartan
WO2013136346A3 (en) Taste masking pharmaceutical orally dissolving strips of lornoxicam

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210617